Westpac Banking Corp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Sell
3,115
-9,502
-75% -$5.16M 0.11% 168
2025
Q4
$7.31M Buy
12,617
+3,930
+45% +$2.22M 0.46% 41
2025
Q3
$4.21M Buy
8,687
+5,573
+179% +$2.59M 0.26% 93
2025
Q2
$1.26M Buy
3,114
+401
+15% +$168K 0.08% 195
2025
Q1
$1.35M Sell
2,713
-628
-19% -$340K 0.1% 193
2024
Q4
$1.74M Hold
3,341
0.12% 177
2024
Q3
$2.07M Buy
3,341
+82
+3% +$48.5K 0.14% 161
2024
Q2
$1.8M Hold
3,259
0.14% 143
2024
Q1
$1.89M Sell
3,259
-42
-1% -$23.6K 0.14% 151
2023
Q4
$1.75M Sell
3,301
-15,310
-82% -$7.41M 0.14% 157
2023
Q3
$9.42M Sell
18,611
-4,349
-19% -$2.32M 0.7% 26
2023
Q2
$12M Sell
22,960
-45,257
-66% -$24.4M 0.85% 20
2023
Q1
$39.3M Sell
68,217
-4,136
-6% -$2.33M 0.53% 27
2022
Q4
$39.8M Buy
72,353
+2,323
+3% +$1.23M 0.59% 24
2022
Q3
$35.5M Sell
70,030
-2,373
-3% -$1.33M 0.54% 23
2022
Q2
$39.3M Sell
72,403
-1,658
-2% -$913K 0.51% 27
2022
Q1
$43.7M Sell
74,061
-5,341
-7% -$3.07M 0.5% 25
2021
Q4
$53M Sell
79,402
-8,252
-9% -$5.15M 0.55% 27
2021
Q3
$50.1M Sell
87,654
-3,471
-4% -$1.91M 0.54% 28
2021
Q2
$46M Sell
91,125
-830
-0.9% -$392K 0.46% 37
2021
Q1
$42M Sell
91,955
-9,971
-10% -$4.76M 0.46% 35
2020
Q4
$47.5M Buy
101,926
+6,276
+7% +$2.94M 0.54% 25
2020
Q3
$42.2M Sell
95,650
-390
-0.4% -$161K 0.57% 25
2020
Q2
$34.8M Sell
96,040
-5,070
-5% -$1.7M 0.52% 27
2020
Q1
$28.7M Sell
101,110
-11,012
-10% -$3.47M 0.49% 34
2019
Q4
$36.4M Sell
112,122
-1,364
-1% -$414K 0.47% 31
2019
Q3
$33.1M Sell
113,486
-6,072
-5% -$1.74M 0.46% 39
2019
Q2
$35.1M Sell
119,558
-10,229
-8% -$2.82M 0.54% 38
2019
Q1
$35.5M Sell
129,787
-129,061
-50% -$32.1M 0.59% 33
2018
Q4
$57.9M Sell
258,848
-13,377
-5% -$3.14M 0.99% 9
2018
Q3
$66.4M Sell
272,225
-15,541
-5% -$3.58M 1.14% 9
2018
Q2
$59.6M Sell
287,766
-8,785
-3% -$1.86M 1.15% 10
2018
Q1
$61.2M Buy
296,551
+26,712
+10% +$5.61M 1.22% 8
2017
Q4
$51.2M Buy
269,839
+28,600
+12% +$5.48M 1.16% 9
2017
Q3
$45.6M Sell
241,239
-2,105
-0.9% -$381K 1% 11
2017
Q2
$42.5M Sell
243,344
-42,266
-15% -$7.1M 0.93% 14
2017
Q1
$43.9M Buy
285,610
+11,779
+4% +$1.8M 0.35% 68
2016
Q4
$39.1M Buy
273,831
+23,576
+9% +$3.48M 0.37% 69
2016
Q3
$39.8M Buy
250,255
+5,818
+2% +$897K 0.43% 48
2016
Q2
$36.1M Buy
244,437
+24,924
+11% +$3.68M 0.4% 49
2016
Q1
$31.1M Buy
219,513
+10,744
+5% +$1.44M 0.34% 63
2015
Q4
$29.6M Buy
208,769
+7,050
+3% +$940K 0.33% 74
2015
Q3
$24.7M Buy
201,719
+12,040
+6% +$1.57M 0.27% 85
2015
Q2
$24.6M Sell
189,679
-14,758
-7% -$1.92M 0.24% 83
2015
Q1
$28M Buy
204,437
+752
+0.4% +$96.9K 0.24% 87
2014
Q4
$25.5M Buy
203,685
+2,246
+1% +$273K 0.24% 97
2014
Q3
$24.5M Sell
201,439
-22,515
-10% -$2.74M 0.24% 92
2014
Q2
$26.4M Buy
223,954
+13,846
+7% +$1.63M 0.25% 93
2014
Q1
$25.3M Sell
210,108
-4,796
-2% -$570K 0.27% 86
2013
Q4
$23.9M Sell
214,904
-7,779
-3% -$774K 0.27% 80
2013
Q3
$20.5M Sell
222,683
-87,030
-28% -$7.87M 0.26% 97
2013
Q2
$23.9M Buy
+309,713
New +$25.8M 0.36% 69

Other funds holding TMO

Westpac Banking Corp's TMO Position: Q1 2026 in Review

Westpac Banking Corp reduced its Thermo Fisher Scientific (TMO) stake by 75% in Q1 2026, selling an estimated $5.16M and leaving 3,115 shares worth $1.53M. The position accounts for 0.11% of the portfolio, ranked #168.

Westpac Banking Corp first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $66.4M in Q3 2018. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Westpac Banking Corp held 3,115 shares of Thermo Fisher Scientific worth $1.53M as of Q1 2026.
  • Westpac Banking Corp sold 9,502 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.16M.
  • Thermo Fisher Scientific made up 0.11% of Westpac Banking Corp's portfolio in Q1 2026, its #168 holding.
  • Westpac Banking Corp first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Westpac Banking Corp's Thermo Fisher Scientific position peaked at $66.4M in Q3 2018.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.